Home Latest Articles
Latest Articles
  • Lingyun LIU, Hairong YANG, Linxiang PAN, Weixiang ZHU
    World Clinical Drug. 2024, 45(10): 1030-1035.
    Objective

    To investigate the effect of iguratimod combined with hydroxychloroquine sulfate on erythrocyte sedimentation rate (ESR) and immune imbalance of helper T cell (Th)17/regulatory T cell (Treg) in patients with primary Sjogren's syndrome (pSS).

    Methods

    A total of 199 pSS patients treated in our hospital from January 2019 to December 2023 were selected and divided into experimental group (n=100, hydroxychloroquine sulfate+iguratimod) and control group (n=99, hydroxychloroquine sulfate) by random number table method. Clinical efficacy, ESR, Th17, Treg, salivary flow rate, tear flow rate, tear film breaking time, and EULAR Sjogren's syndrome patient reported index (ESSPRI), EULAR Sjogren's syndrome disease activity index (ESSDAI) and the incidence of adverse reactions were compared between the two groups before and after treatment.

    Results

    After treatment, the total effective rate of experimental group was higher than that of control group (91.00% vs 79.80%, P<0.05). The levels of ESR and Th17 in two groups were significantly lower than before (P<0.05), and those in experimental group were lower than those in control group (P<0.05). The level of Treg in both groups were significantly higher than before (P<0.05), and the experimental group was higher than the control group. The salivary flow rate, tear flow rate and tear film breaking time of the two groups were significantly increased (P<0.05), and the experimental group was higher than the control group (P<0.05). The scores of ESSPRI and ESSDAI in two groups were significantly lower than before (P<0.05), and the experimental group was lower than the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the experimental group and the control group during treatment (3.00% vs 5.05%, P>0.05).

    Conclusion

    Iguratimod combined with hydroxychloroquine sulfate has better effect on pSS, and can effectively improve the immune imbalance of ESR and Th17/Treg.

  • Xiaowen CAO, Lu YE, Shuo FENG, Yuanxiao FAN, Shaokang LI, Jiwei FENG
    World Clinical Drug. 2024, 45(10): 1036-1040.
    Objective

    To observe the clinical effect of acupuncture combined with Shenqi Dihuang decoction in the treatment of chronic glomerulonephritis (CGN) of Qi and Yin deficiency type.

    Methods

    A total of 96 CGN patients diagnosed in Gongli Hospital of Shanghai Pudong New Area from October 2020 to March 2024 were randomly divided into treatment group and control group, with 48 cases in each group. The control group was treated with basic western medicine, and the treatment group was treated with traditional Chinese medicine combined with acupuncture for 8 weeks. The total effective rate, interleukin (IL)-2, urinary erythrocyte, 24 h urinary protein quantity (24 h UPro), serum creatinine (Scr) and blood urea nitrogen (BUN) levels were compared between the two groups.

    Results

    After treatment, the levels of Scr, 24 h UPro and IL-2 level in the treatment group were all decreased (P<0.05), and the treatment group was lower than the control group (P<0.05). The total effective rate of treatment group was higher than that of control group (83.33% vs 64.58%, P<0.05). There were no obvious adverse reactions in both groups.

    Conclusion

    Acupuncture combined with Shenqi Dihuang decoction is effective and safe in treating CGN of Qi and Yin deficiency type, and the mechanism of action may be related to the regulation of immune factors.

  • Xiaofang XIE, Yankong LI, Guang ZHANG, Zesheng LIU, Xin LI
    World Clinical Drug. 2024, 45(10): 1041-1045.
    Objective

    To investigate the curative effect of modified Shaoyao and Gancao decoction combined with pregabalin in the treatment of malignant neuropathic pain (MNP).

    Methods

    A total of 140 MNP patients admitted to our hospital from September 2022 to September 2023 were randomly divided into western medicine group (pregabalin) and Chinese and western medicine combined group (pregabalin combined with modified Shaoyao Gancao decoction), with 70 cases in each group. The clinical efficacy, pain mediator levels, quality of life and adverse reactions were compared between two groups.

    Results

    The total effective rate of the combined treatment group (91.43%) was higher than that of the western medicine group (75.71%, P<0.05). After treatment, the levels of 5-hydroxytryptamine, Substance P, prostaglandin E2 and endothelin-1 in the combined group were significantly lower than those in the western medicine group (P<0.05). The score of quality of life (QOL) in the combined medicine group was significantly decreased (P<0.05). There was no statistical significance in the incidence of adverse reactions between the two groups (P>0.05).

    Conclusion

    Modified Shaoyao Gancao decoction combined with pregabalin can effectively relieve pain in MNP patients, improve clinical efficacy and quality of life, and have good safety.

  • Lu ZHANG, Shuzheng LIU, Rui ZHANG, Li'na YANG, Zhuojun LI
    World Clinical Drug. 2024, 45(10): 1046-1052.
    Objective

    To analyze the efficacy and safety of cefoperazone sulbactam sodium combined with high-dose tigecycline in the treatment of interleukin (IL)-6, procalcitonin (PCT) and other indicators in patients with complicated urinary tract infection.

    Methods

    A total of 156 patients with complicated urinary tract infection caused by carbapenem-resistant Acinetobacter baumannii (CRAB) admitted to the Affiliated Hospital of Tangshan Vocational and Technical College from August 2020 to December 2023 were selected as retrospective study objects. The patients were divided into the high dose group and the routine dose group according to the dose of tigecycline, with 78 cases in each group. The initial dose of tigecycline in the high dose group was 200 mg, and the maintenance dose was 100 mg, twice a day. The initial dose of tigecycline in the routine dose group was 100 mg, and the maintenance dose was 50 mg, twice a day. The clinical efficacy, clinical indexes negative time, the laboratory indexe [IL-6, IL-8, hypersensitive C-reactive protein (hs-CRP) and PCT], the negative rate of urine culture, the incidence of adverse reactions and the oxidative stress indexes [noradrenaline (NE), glutathione peroxidase (GSH-PX), angiotensinogenⅡ (AngⅡ)] and treatment satisfaction were analyzed between the two groups.

    Results

    The total clinical effective rate of the high-dose group was significantly higher than that of the routine dose group (P<0.05). The time of clinical symptoms disappearing, the time of urine white blood cell turning negative, and the time of fever reduction in the high-dose group were significantly shorter than those in the routine dose group (P<0.05). The levels of IL-6, IL-8, hs CRP, and PCT in the high-dose group were significantly lower than those in the routine dose group after treatment (P<0.05). The negative conversion rate of urine culture in the high-dose group was higher than that in the routine dose group (23.36% vs 12.82%, χ2=3.431, P=0.009). The total incidence of adverse reactions in the high-dose group was higher than that in the routine dose group (P>0.05), and the overall treatment satisfaction rate in the high-dose group was higher than that in the routine dose group (96.15% vs 82.05%, P<0.05). The levels of NE, GSH-Px, and AngⅡ in the high-dose group were significantly higher than those in the routine dose group after treatment (P<0.05).

    Conclusions

    High-dose tigecycline combined with cefoperazone-sulbactam sodium has significant efficacy in the treatment of CRAB induced complicated urinary tract infection, and the adverse reactions are not significantly higher than that of the routine dose regimen, and is safe and effective.

  • Xingqiang CHEN, Guoliang ZENG, Shaolian CAI
    World Clinical Drug. 2024, 45(10): 1053-1057.
    Objective

    To investigate the effects of levothyroxine replacement therapy on subclinical hypothyroidism (SCH) after menopause.

    Methods

    A total of 90 postmenopausal SCH patients diagnosed in the First People's Hospital of Zhaoqing from January 2020 to June 2022 were selected as research objects and divided into control group and study group according to simple sort randomization method, with 45 cases in each group. The control group received conventional symptomatic treatment, and the study group received levothyroxine replacement treatment. The clinical effective rate, thyroid function, blood lipid level and the occurrence of adverse reactions were compared between the two groups.

    Results

    After treatment, the total effective rate of the study group was higher than that of the control group (95.56% vs 80.00%, P<0.05). After treatment, there were no significant differences between the two groups in the levels of free triiodothyronine, serum free thyroxine and anti-thyroid peroxidase antibody (P>0.05), but the level of thyroid stimulating hormone (TSH) in the study group was higher than that in the control group (P<0.05). The levels of total cholesterol, triglyceride and low density lipoprotein cholesterol in the study group were lower than those in the control group (P<0.05), and the level of high density lipoprotein cholesterol was higher than that in the control group (P<0.05). There was no significant difference in the occurrence of adverse reactions between the two groups (P>0.05).

    Conclusion

    Levothyroxine replacement therapy is an effective and feasible medication regimen for postmenopausal SCH patients, which can help control TSH level, regulate blood lipid, and has good drug safety.

  • Lijie WANG, Erjun XU, Xin LYU, Xiaomin SUN, Qimin XU
    World Clinical Drug. 2024, 45(10): 1058-1066.
    Objective

    To explore the effect of national volume-based procurement (NVBP) policy on the use of anti-tumor drugs in a tertiary A general hospital, and to provide rational advices for improving quantity of drug policies and enhancing hospital pharmaceutical management.

    Methods

    Descriptive statistical methods were used to compare usage quantity, consumption volumes, defined daily dose system (DDDs), defined daily dose cost (DDDc), daily cost ratio and B/A before and after the implementation of NVBP policy of anti-tumor drugs.

    Results

    After the implementation of NVBP policy, the total usage amount of anti-tumor drugs increased from 49 666.35 g to 105 870.91 g, with an increase of 113.16%, the total consumption sum decreased from CNY 13.699 9 million to CNY 4.917 9 million, with a decrease of 64.10%. The DDDc of anti-tumor drugs all showed a decreasing trend, with the daily cost ratio was less than 1.0, a total of 33.814 4 million was saved in expenses, the proportion of usage amount, DDDs, and consumption sum of bid-winning tumor drugs were 100.00%, 99.38%, and 99.30%, respectively.

    Conclusion

    After the implementation of the national volume-based procurement policy in a tertiary comprehensive hospital, the cost of anti-tumor drugs has significantly decreased, which significantly reduces the economic burden on patients, reduces the operating costs of the hospital, and promotes a more reasonable distribution of medical insurance funds.

  • Danhua SUN, Li'na DENG, Jingjing HAN, Xiuli JU, Guofang LIU, Wen DONG
    World Clinical Drug. 2024, 45(10): 1067-1071.
    Objective

    Analyze the clinical efficacy of the combination of denoprorelin suppositories and rivanol for induced labor in scarred uterus.

    Methods

    A total of 98 patients with scarred uterus in the second trimester of pregnancy who were admitted to Port Hospital of Hebei Port Group Co., Ltd. and Changli County Maternal and Child Health Hospital from February 2020 to February 2022 were selected as the research objects. According to the induction protocol, they were divided into the control group (rivanol treatment) and the study group (rivanol+desoprostone suppository treatment), with 49 cases in each group. The perioperative indicators, cervical maturity, success rate of induced labor, adverse reactions and postoperative complications were compared between the two groups.

    Results

    Compared with the control group, the time of uterine contraction initiation, fetal delivery and hospital stay in the study group were significantly shortened (P<0.05). The blood loss during labor induction and 2 h after labor induction in the study group was significantly lower than that in the control group (P<0.05). Bishop score of cervical maturity in study group was higher than that in control group at 6 h, 12 h and 18 h after treatment (P<0.05). The total induced labor rate of the study group (95.92%) was significantly higher than that of the control group (87.76%, P<0.05).

    Conclusion

    Dinoprostione suppository combined with rivanol for inducing labor in scarred uterus of second trimester has good outcome and has clinical promotion potential.

  • Yu ZHANG, Yuhan GU, Zhuo WANG, Zhixin ZHENG, Ping ZHU
    World Clinical Drug. 2024, 45(10): 1072-1077.
    Objective

    To investigate the safety and efficacy of doxycycline in the treatment of lobular pneumonia infected by drug-resistant Mycoplasma pneumoniae (MP) in children.

    Methods

    Children with lobular pneumonia infected by drug-resistant MP admitted to our hospital from July 2023 to April 2024 were selected as the study objects, and their clinical manifestations, etiology detection, laboratory and imaging examination, clinical efficacy and safety were collected and analyzed during hospitalization.

    Results

    Among the 65 patients, there were 34 males and 31 females, of which 28 were ≥8 years old and 37 were <8 years old, with an average age of (7.73±2.41) years. The most common clinical manifestations were cough (65 cases, 100.0%) and fever (64 cases, 98.46%). The right lung was mainly involved in pneumonia (33 cases, 50.77%). The average course of treatment with doxycycline was (7.43±2.95) days, with a dosage of 2 mg/kg every 12 hours. After treatment, the average body temperature of 50 cases (76.92%) dropped to normal within (1.76±1.20) days, 55 cases (84.62%) showed significantly improvement in cough symptoms within (3.58±1.89) days, and 54 cases (83.08%) showed significant absorption in lung imaging, with an average time of (9.00±0.63) days. There was 1 case of rash and 1 case of pain during medication period. After discharge, follow-up was conducted until 3 months after medication, and no drug-related adverse reactions occurred.

    Conclusion

    Doxycycline is safe in the treatment of lobular pneumonia infected by drug-resistant MP in children with proper dose and short course of treatment, and can be appropriately selected in clinical pratice.

  • Yuan XU, Jia WANG, Yanhui YANG, Rong LI, Hu YANG, Chunyan SHAN
    World Clinical Drug. 2024, 45(10): 1078-1084.
    Objective

    To collect the medical records of patients with diabetic kidney disease (DKD) during the course of Shenyan Kangfu tablets, and to analyze the clinical features of Shenyan Kangfu tablets in the treatment of DKD and the improvement of renal function in the real world.

    Methods

    Based on the hospital electronic medical record information system, 503 cases of DKD patients with prescription Shenyan Kangfu tablets from October 1, 2016 to October 31, 2021 were collected to analyze the characteristics of the population taking Shenyan Kangfu tablets in the real world, the distribution of drug diseases, the improvement of renal function, the safety and the combined treatment plan, and to evaluate its efficacy and safety.

    Results

    The age of DKD patients taking Shenyan Kangfu tablets was mainly 30~80 years old, of which 50~60 years old accounted for 33.20% and 60~70 years old accounted for 30.22%. There were more males than females (67.40% vs 32.60%). The results showed that Shenyan Kangfu tablets could significantly reduce urinary protein, urinary albumin/creatinine ratio (ACR), glycosylated hemoglobin (Hb) A1c and other indexes at 24 h. After taking Shenyan Kangfu tablets for 3 months, 24 h urinary protein level increased, hemoglobin, serum albumin, HbA1c levels decreased. During 3 to 6 months, 24 h urinary protein, creatinine and HbA1c levels decreased. After 6 months, ACR levels increased and 24 h urinary protein and HbA1c levels decreased. No adverse reactions were recorded during the administration, and the safety was good. Clinical drug combinations mainly include blood glucose control drugs, blood pressure control drugs, lipid-regulating drugs, etc.

    Conclusion

    There are more DKD patients using Shenyan Kangfu tablet in clinical practice, and the preliminary results show that Shenyan Kangfu tablet combined with conventional western medicine treatment of DKD is safe and effective.

  • Bojian WU, Teng HUANG, Jun XIE, Pei LU, Shaozhong PENG, Xiaodan HUANG
    World Clinical Drug. 2024, 45(10): 1085-1090.
    Objective

    To investigate the clinical efficacy and safety of rheum and pharyngitis oral solution in the treatment of upper respiratory system diseases in children in the real world, and to analyze the correlation between adverse reactions and medication regimen through multi-center retrospective study.

    Methods

    The medical records of 500 children using rheum and pharyngitis oral solution in target centers from May 31, 2016 to May 31, 2022 were collected, and their age, gender, department of treatment, purpose of diagnosis and treatment, drug use, laboratory test results and drug combination information were analyzed.

    Results

    The mean age of the patients was (7.80±3.45) years old. The patients above 6 years old accounted for 56%, followed by the patients between 3 and 6 years old (44.00%). The department with the highest number of patients was pediatrics (57.14%). Acute upper respiratory tract infection (89.20%) was the highest proportion of rheum and pharyngitis oral solution, and Chinese medicine (39.80%) was the highest proportion of rheum and pharyngitis oral solution combined drugs. There were significant differences in single dose, days of medication, total daily dose and total dose of medication cycle between the two age groups (P<0.05). There were no significant differences in blood routine, C-reactive protein and renal function indexes between the first examination and the last examination (P>0.05).

    Conclusion

    At present, rheum and pharyngitis oral solution is mainly used in the adjuvant treatment of upper respiratory system diseases in children, and the efficacy of rheum and pharyngitis oral solution is highly recognized by clinicians.

News